KIORA PHARMACEUTICALS, INC. Accrued Liabilities, Current
KIORA PHARMACEUTICALS, INC. (KPRX) had Accrued Liabilities, Current of $1.98 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Accrued Liabilities, Current $1.98M.
- 2026-03-31: Accrued Liabilities, Current $2.03M.
- 2025-12-31: Accrued Liabilities, Current $2.41M.
- 2025-09-30: Accrued Liabilities, Current $2.15M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $1.98M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $2.03M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $2.41M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $2.15M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.54M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $3.52M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $4.59M 10-K · filed 2026-03-25 |
| 2024-09-30 | $1.71M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.35M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.22M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.38M 10-K · filed 2025-03-25 |
| 2023-09-30 | $1.46M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.40M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.18M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.84M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.80M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.63M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.83M 10-Q · filed 2022-07-08 |
| 2021-12-31 | $1.33M 10-K · filed 2023-03-23 |
| 2021-09-30 | $1.39M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $974.07K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $885.46K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.29M 10-K/A · filed 2022-07-07 |
| 2020-09-30 | $809.05K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $618.87K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $491.08K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.12M 10-K · filed 2021-03-25 |
| 2019-09-30 | $982.60K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $737.73K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $578.04K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.11M 10-K · filed 2020-03-04 |
| 2018-09-30 | $1.15M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $1.04M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $1.41M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $1.81M 10-K · filed 2019-03-01 |
| 2017-09-30 | $1.72M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.17M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $862.85K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $1.67M 10-K · filed 2018-03-02 |
| 2016-09-30 | $1.34M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $1.31M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $910.66K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $1.10M 10-K · filed 2017-02-23 |
| 2015-09-30 | $250.81K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $305.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $126.51K 10-Q · filed 2015-05-18 |
| 2014-12-31 | $913.06K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |